Cash Flow Jubilant Pharmo Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
614.00
980.00
170.00
27.00
630.00
1,212.00
Adjustment
682.00
218.00
755.00
782.00
579.00
716.00
Changes In working Capital
139.00
111.00
253.00
54.00
-178.00
249.00
Cash Flow after changes in Working Capital
1,436.00
1,310.00
1,179.00
865.00
1,031.00
2,178.00
Cash Flow from Operating Activities
1,226.00
1,072.00
971.00
660.00
837.00
1,784.00
Cash Flow from Investing Activities
-1,142.00
512.00
-596.00
-473.00
-323.00
-726.00
Cash Flow from Financing Activities
94.00
-1,452.00
-432.00
-156.00
-32.00
-1,709.00
Net Cash Inflow / Outflow
178.00
131.00
-57.00
30.00
481.00
-651.00
Opening Cash & Cash Equivalents
1,088.00
956.00
1,013.00
983.00
501.00
1,153.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1,267.00
1,088.00
956.00
1,013.00
983.00
501.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jubilant Pharmo
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
33.5
654.13
-621.00
-94.88%
Adjustment
42.8
80.72
-38.00
-46.98%
Changes In working Capital
23.1
-180.38
203.00
112.81%
Cash Flow after changes in Working Capital
99.4
554.48
-455.00
-82.07%
Cash Flow from Operating Activities
93.6
391.52
-298.00
-76.09%
Cash Flow from Investing Activities
34
-615.65
649.00
105.52%
Cash Flow from Financing Activities
-129.9
-6.23
-123.00
-1985.07%
Net Cash Inflow / Outflow
-2.3
-230.35
228.00
99.00%
Opening Cash & Cash Equivalents
12.6
301.41
-289.00
-95.82%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
10.3
71.06
-61.00
-85.51%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 14.43% vs 10.38% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,226.80
1,072.10
14.43%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
